loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for ETHYL 4-(13-CHLORO-4-AZATRICYCLO[9.4.0.0(3,8)]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE)PIPERIDINE-1-CARBOXYLATE? Find Controlled & Modified Release used in ETHYL 4-(13-CHLORO-4-AZATRICYCLO[9.4.0.0(3,8)]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE)PIPERIDINE-1-CARBOXYLATE to address drug delivery challenges on PharmaCompass.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    View Presentation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    ETHYL 4-(13-CHLORO-4-AZATRICYCLO[9.4.0.0(3,8)]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE)PIPERIDINE-1-CARBOXYLATE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 333Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Gangwal Healthcare

    02 5Nanjing Well Pharmaceutical

    03 2Actylis

    04 2Aeon Procare

    05 20BASF

    06 3Corel Pharma Chem

    07 4Finar

    08 3Ideal Cures Pvt Ltd

    09 14Kerry

    10 1Kima Chemical

    11 1Lonza Capsugel

    12 2Nomisma Healthcare

    13 1Sigachi Industries

    14 5The Dow Chemical Company

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® SR300

    Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Brand : DICOM-DC® SR300

    Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare DiCOM-DC® SR300

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Nanjing Well Pharmaceutical

    China
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Grade : Parenteral, Topical, Oral

    Brand Name : Polyethylene Glycol 400

    Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Ingredient(s) : Polyethylene Glycol 400

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Grade : Parenteral, Topical, Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : Polyethylene Glycol 400

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Brand : POLYETHYLENE GLYCOL 400

    Applications : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Grade : Parenteral, Topical, Oral

    arrow
    Nanjing Well Polyethylene Glycol 400 NF

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    Brand Name : Gellets-P®

    Application : Controlled & Modified Release

    Excipient Details : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Category : Controlled & Modified Release

    Brand : GELLETS-P®

    Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare Gellets-P®

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    04

    BASF

    KOLLIDON SR

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    Brand Name : Kollidon SR

    Application : Controlled & Modified Release, Direct Compression, Granulation

    Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...

    Technical Specs :

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Category : Controlled & Modified Release, Direct Compression, Granulation

    Brand : KOLLIDON SR

    Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Kerry

    SHEFFCEL

    arrow
    2024 ACI Convention
    Not Confirmed

    06

    The Dow Chemical Company

    ETHOCEL™

    arrow
    2024 ACI Convention
    Not Confirmed

    07

    Nomisma Healthcare

    PLLA-PEG

    arrow
    2024 ACI Convention
    Not Confirmed

    08

    Aeon Procare

    TALC

    arrow
    2024 ACI Convention
    Not Confirmed

    09

    Nomisma Healthcare

    PLGA-PEG

    arrow
    2024 ACI Convention
    Not Confirmed

    Nomisma Healthcare

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    Brand Name : PLGA-PEG

    Application : Controlled & Modified Release

    Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : PLGA-PEG

    Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    10

    Kerry

    SHEFFCEL CR

    arrow
    2024 ACI Convention
    Not Confirmed

    11

    Finar

    POLYETHYLENE GLYCOL 400

    arrow
    2024 ACI Convention
    Not Confirmed

    12

    Ideal Cures Pvt Ltd

    ESPHERES EM

    arrow
    2024 ACI Convention
    Not Confirmed

    Ideal Cures Pvt Ltd

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Espheres EM

    Application : Controlled & Modified Release

    Excipient Details : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

    Pharmacopoeia Ref : Particle Sizes - #20 – #30, ...

    Technical Specs :

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : ESPHERES EM

    Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

    Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    13

    Ideal Cures Pvt Ltd

    INSTAMODEL BLEND

    arrow
    2024 ACI Convention
    Not Confirmed

    14

    Sigachi Industries

    HICEL MCC SPHERES

    arrow
    2024 ACI Convention
    Not Confirmed

    15

    Kerry

    SHEFFCOAT™ S

    arrow
    2024 ACI Convention
    Not Confirmed

    16

    The Dow Chemical Company

    METHOCEL™

    arrow
    2024 ACI Convention
    Not Confirmed

    The Dow Chemical Company

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet, Capsule

    Grade :

    Brand Name : METHOCEL™

    Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Brand : METHOCEL™

    Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    17

    Kerry

    SHEFFCOAT™ENHANCE

    arrow
    2024 ACI Convention
    Not Confirmed

    18

    Kima Chemical

    HYDROXYPROPYL METHYL CELLULOSE (75K100)

    arrow
    2024 ACI Convention
    Not Confirmed

    19

    Ideal Cures Pvt Ltd

    INSTANUTE DR

    arrow
    2024 ACI Convention
    Not Confirmed

    Ideal Cures Pvt Ltd

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Instanute DR

    Application : Coating Systems & Additives, Controlled & Modified Release

    Excipient Details : INSTANUTE DR is a ready-to-use film coating system, based on Sodium Alginate which confers pH/solubility characteristics, making it suitable for nutritional applications requiring delayed release properties.

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Sodium Alginate Excipient

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Sodium Alginate Excipient

    Dosage Form : Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release

    Brand : INSTANUTE DR

    Applications : INSTANUTE DR is a ready-to-use film coating system, based on Sodium Alginate which confers pH/solubility characteristics, making it suitable for nutritional applications requiring delayed release properties.

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    20

    Kerry

    SHEFFCOAT™ GLIDE

    arrow
    2024 ACI Convention
    Not Confirmed

    21

    Kerry

    SHEFFCOAT™ L

    arrow
    2024 ACI Convention
    Not Confirmed

    22

    Kerry

    SHEFFCOAT™

    arrow
    2024 ACI Convention
    Not Confirmed

    23

    Lonza Capsugel

    VCAPS® ENTERIC

    arrow
    2024 ACI Convention
    Not Confirmed

    Lonza Capsugel

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule

    Grade : Oral

    Brand Name : Vcaps® Enteric

    Application : Controlled & Modified Release, Vegetarian Capsules

    Excipient Details : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant Europea...

    Technical Specs : Water content – less than 6%; Size #0

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Category : Controlled & Modified Release, Vegetarian Capsules

    Brand : VCAPS® ENTERIC

    Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

    Technical Specs : Water content – less than 6%; Size #0

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    24

    Kerry

    SHEFFCOAT™ CG

    arrow
    2024 ACI Convention
    Not Confirmed

    25

    Kerry

    SHEFFCOAT™ D

    arrow
    2024 ACI Convention
    Not Confirmed

    26

    Actylis

    POLYETHYLENE GLYCOL 400

    arrow
    2024 ACI Convention
    Not Confirmed

    27

    Kerry

    SHEFFCOAT™ EC

    arrow
    2024 ACI Convention
    Not Confirmed

    28

    Kerry

    SHEFFCOAT™ HS

    arrow
    2024 ACI Convention
    Not Confirmed

    29

    Kerry

    SHEFFCOAT™ MP

    arrow
    2024 ACI Convention
    Not Confirmed

    30

    BASF

    KOLLICOAT SR 30 D

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    Brand Name : Kollicoat SR 30 D

    Application : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...

    Technical Specs :

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Category : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Brand : KOLLICOAT SR 30 D

    Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    31

    Corel Pharma Chem

    NUTRACOAT EC25D

    arrow
    2024 ACI Convention
    Not Confirmed

    Corel Pharma Chem

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    Brand Name : Nutracoat EC25D

    Application : Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers, Granulation, Taste Masking

    Excipient Details : Sustained Release, Taste Masking, Moisture Barrier, Binder in Wet Granulation

    Pharmacopoeia Ref : USP/NF: Ethyl cellulose disper...

    Technical Specs :

    Ingredient(s) : Ethyl Cellulose

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Ethyl Cellulose

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Category : Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers, Granulation, Taste Masking

    Brand : NUTRACOAT EC25D

    Applications : Sustained Release, Taste Masking, Moisture Barrier, Binder in Wet Granulation

    Pharmacopoeia Ref : USP/NF: Ethyl cellulose dispersion Type B

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    32

    BASF

    KOLLIDON 25

    arrow
    2024 ACI Convention
    Not Confirmed

    33

    BASF

    KOLLIDON 30

    arrow
    2024 ACI Convention
    Not Confirmed

    34

    BASF

    SOLUPLUS

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Grade :

    Brand Name : Soluplus

    Application : Controlled & Modified Release, Granulation, Solubilizers

    Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

    Pharmacopoeia Ref : Polyvinyl caprolactam – poly...

    Technical Specs :

    Ingredient(s) : polyethylene glycol, Polyvinyl Acetate

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : polyethylene glycol, Polyvinyl Acetate

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Category : Controlled & Modified Release, Granulation, Solubilizers

    Brand : SOLUPLUS

    Applications : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

    Pharmacopoeia Ref : Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth